Introduction
Mycetoma is a late-stage infection, characterized by a chronic localized indurate, and is a slowly progressive and often painless cutaneous or subcutaneous disease. Usually, hands, feet, legs or arms are involved and macroscopically visible grains of various sizes and colours often are considered pathognomonic. Mycetoma is a globally distributed disease and is considered endemic in tropical and subtropical regions. In Mexico, 86 % of cases are caused by Nocardia brasiliensis (Ameen & Arenas, 2009; Ló pez-Martínez et al., 1992) . Members of the genus Nocardia are found in soil, dust, sand, decaying vegetable matter and aquatic environments (Fahal, 2004) . The main route of acquisition is through direct inhalation of contaminated particles or by direct inoculation through the skin (Brown-Elliott et al., 2006) . (Seo & Lee, 2006) . To our knowledge, no clinical cases have been reported or associated with this species since it was first identified. We believe this to be the first report of N. harenae obtained from a clinical case in the Mexican Caribbean.
Case one
The first case was a 63-year-old female, native to Campeche, Mexico, who had a 20-year history of multiple small sinus tracts, local inflammation and purulent discharge from her right thigh and knee (Fig. 1) . On examination at the 'Dr Fernando Latapi' Dermatological Center, Yucatan, Mexico, the patient presented with anaemia and leukopenia. She was treated with iron, folic acid and an immunostimulant (Ismigen); no liver disorders were detected. Previously, the patient had received multiple treatments, which included use of the following antibiotics: trimethoprim-sulfamethoxazole and dapsone, clofazimine, rifampicin, amikacin, gatifloxacine and amoxicillin/clavulanic acid.
Direct examination showed small multilobular grains of Nocardia (100-200 mm). Culture on Sabouraud dextrose agar showed chalky growth with tiny hyphae, which tested positive for acid-fast filaments using Kinyoun stain. No sensitivity tests were performed. The isolate was identified as N. harenae strain 441. The recommended treatment included intravenous injections of amikacin (1 mg kg 21 ) and imipenem (500 mg) three times a day for 8 days and partial remission was observed with six lesions persisting. Follow-up treatment with trimethoprim/sulfamethoxazole (160/800 mg day 21 ), dapsone (100 mg day
21
) and mynociclin (100 mg day 21 ) was recommended for the next 2 years until the patient was clinically cured.
Case two
The second case was a 34-year-old male, native to Ucu, Yucatan, Mexico, who was first examined at the 'Dr. Fernando Latapi' Dermatological Center, Yucatan, Mexico. The patient presented small nodular lesions with no secretion on his left forearm (Fig. 2) with a 1 year history of asymptomatic sinus tracts. Direct examination showed small multilobular grains. Culture on Sabouraud dextrose agar showed white colonies with tiny hyphae, which tested positive for acid-fast filaments using Kinyoun stain. No susceptibility tests were performed. The isolate was identified as N. harenae strain 21. Treatment comprised a multidrug therapy of trimethoprim/sulfamethoxazole (800/160 mg day
21
) and dapsone (100 mg day
) for 10 months. This resulted in complete remission, which was confirmed after 2 years of follow-up examinations.
Molecular identification of isolates from both cases was achieved by 16S rRNA gene sequencing, using a set of primers (59-GGATCCTTTTGATCCTGGCTCAGGAC-39 and 59-ACTTGACGTCGTCCCCACCTTCCTC-39) that were designed based on the 16S rRNA gene sequence of Nocardia wallacei ATCC 49872, formerly Nocardia asteroides (accession number AY191251), to amplify a PCR product of 1120 bp. The PCR fragments were purified and sequenced in both directions. The sequences displayed 100 % identity with N. harenae CDC ,USA-GA .:W9742 (acc no. GQ376170) and N. harenae strain WS-26 T (acc no. DQ282122); and 97 % identity with Nocardia transvalensis N630 (acc no. Z82240.1) and Nocardia asiatica CDC ,USA-GA .:W8323 (acc no. GQ217495). The complete 16S rRNA gene sequences determined for both N. harenae strains 441 and 21 have been deposited in GenBank under accession numbers HQ896358 and JF264836, respectively.
Discussion
Many Nocardia species have been implicated in human infections but the geographical prevalence of each species throughout the world may differ dramatically and some are uncommon. The cases reported herein are interesting because they are believed to be the first cases of mycetoma due to N. harenae in a country where N. brasiliensis is the prevalent aetiological agent of mycetoma. N. harenae was first characterized by Seo & Lee (2006) as a novel species that differed from the previously described members of the genus Nocardia by its molecular and biochemical characteristics.
In the present cases, the direct examination of the grains, followed by determination of phenotypic characteristics of colonies in Sabouraud culture (Muñoz et al., 2007) , suggested N. S. Kresch-Tronik and others probable cases of N. brasiliensis infection but further examination using molecular techniques allowed the precise identification of N. harenae as the aeteological agent. Nowadays, the development of specific molecular techniques makes it possible to accurately identify species capable of infecting humans and, combined with conventional methods, these tools proved useful in obtaining an accurate Nocardia diagnosis (Brown-Elliott et al., 2006; Roth et al., 2003; Conville et al., 2010) . 16S rRNA gene sequencing has been used for identification at the species level, resulting in a considerable reclassification of members of the genus Nocardia, and, due to their distinctive and unique sequence arrangements, it is considered the gold standard for identification of these organisms (Roth et al., 2003; Conville et al., 2010) .
Clinical experience and in vitro antibiotic susceptibility analysis have shown that the management of Nocardia infections must be individualized. Nocardia actinomycetoma is usually managed with an empirical therapy. For patients with local or disseminated disease, a three-drug regimen consisting of trimethoprim/sulfamethoxazole, amikacin, and either ceftriaxone or imipenem is preferred because using these drugs in combination prevents drug resistance, eradicates any residual infection and covers all clinical isolates (Brown-Elliott et al., 2006) . Remarkably, the chosen treatment of a carbapenem with broad microbicidal activity confirmed our previous observations in that imipenem showed an impressive clinical response (Fuentes et al., 2006; Ameen et al., 2010 Ameen et al., , 2011 .
The experience described herein will lead to the improvement of patient care and facilitate research into the pathogenesis and epidemiology of Nocardia-related disease. However, further studies are required to validate these observations. In these cases, we used molecular methods to accurately identify the causative agent, leading to better case management and treatment. The total remission in both of these cases proved that the correct course of treatment was chosen.
